期刊
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
卷 16, 期 21, 页码 5687-5690出版社
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.bmcl.2006.08.017
关键词
prolyl hydroxylase inhibitors; HIFI-alpha; hypoxia; ischemia; peripheral arterial disease (PAD); anemia; pyrazolopyridines
Recently resolved X-ray crystal structure of HIF-1 alpha prolyl hydroxylase was used to design and develop a novel series of pyrazolopyridines as potent HIF-1 alpha prolyl hydroxylase inhibitors. The activity of these compounds was determined in a human EGLN-1 assay. Structure-based design aided in optimizing the potency of the initial lead (2, IC50 of 11 mu M) to a potent (11I, 190 nM) EGLN-1 inhibitor. Several of these analogs were potent VEGF inducers in a cell-based assay. These pyrazolopyridines were also effective in stabilizing HIF-1 alpha. (c) 2006 Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据